Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer's Disease Neuroimaging Initiative Control Group Life Science Investing
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy Life Science Investing
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral renal denervation system Medical Device Investing
Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets Life Science Investing
Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 Life Science Investing
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635 Life Science Investing
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE Life Science Investing
